The iLet Experience Study

RecruitingOBSERVATIONAL
Enrollment

1,875

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Type 1 Diabetes
Interventions
DEVICE

iLet Dosing Decision Software

Interoperable alternate glycemic controller

Trial Locations (1)

92618

RECRUITING

Beta Bionics, Irvine

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

The Scripps Research Institute

OTHER

lead

Beta Bionics, Inc.

INDUSTRY